Talis Biomedical Statistics
Total Valuation
TLIS has a market cap or net worth of $15.49 million. The enterprise value is -$35.61 million.
| Market Cap | 15.49M |
| Enterprise Value | -35.61M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TLIS has 1.82 million shares outstanding. The number of shares has increased by 0.51% in one year.
| Shares Outstanding | 1.82M |
| Shares Change (YoY) | +0.51% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 8.31% |
| Owned by Institutions (%) | 43.50% |
| Float | 1.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.66 |
| Forward PS | n/a |
| PB Ratio | 0.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.52, with a Debt / Equity ratio of 0.34.
| Current Ratio | 7.52 |
| Quick Ratio | 7.43 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -75.40% and return on invested capital (ROIC) is -81.57%.
| Return on Equity (ROE) | -75.40% |
| Return on Assets (ROA) | -56.20% |
| Return on Capital (ROIC) | -81.57% |
| Revenue Per Employee | $9,990 |
| Profits Per Employee | -$577,889 |
| Employee Count | 99 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.14% in the last 52 weeks. The beta is 1.69, so TLIS's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | +18.14% |
| 50-Day Moving Average | 8.96 |
| 200-Day Moving Average | 7.76 |
| Relative Strength Index (RSI) | 43.67 |
| Average Volume (20 Days) | 6,770 |
Short Selling Information
The latest short interest is 13,410, so 0.74% of the outstanding shares have been sold short.
| Short Interest | 13,410 |
| Short Previous Month | 13,399 |
| Short % of Shares Out | 0.74% |
| Short % of Float | 1.32% |
| Short Ratio (days to cover) | 2.31 |
Income Statement
In the last 12 months, TLIS had revenue of $989,000 and -$57.21 million in losses. Loss per share was -$31.43.
| Revenue | 989,000 |
| Gross Profit | 962,000 |
| Operating Income | -61.94M |
| Pretax Income | -57.21M |
| Net Income | -57.21M |
| EBITDA | -52.43M |
| EBIT | -57.21M |
| Loss Per Share | -$31.43 |
Balance Sheet
The company has $70.34 million in cash and $19.24 million in debt, giving a net cash position of $51.10 million or $28.04 per share.
| Cash & Cash Equivalents | 70.34M |
| Total Debt | 19.24M |
| Net Cash | 51.10M |
| Net Cash Per Share | $28.04 |
| Equity (Book Value) | 56.68M |
| Book Value Per Share | 31.11 |
| Working Capital | 61.70M |
Cash Flow
In the last 12 months, operating cash flow was -$43.20 million and capital expenditures -$432,000, giving a free cash flow of -$43.63 million.
| Operating Cash Flow | -43.20M |
| Capital Expenditures | -432,000 |
| Free Cash Flow | -43.63M |
| FCF Per Share | -$23.95 |
Margins
Gross margin is 97.27%, with operating and profit margins of -6,262.39% and -5,784.73%.
| Gross Margin | 97.27% |
| Operating Margin | -6,262.39% |
| Pretax Margin | -5,784.73% |
| Profit Margin | -5,784.73% |
| EBITDA Margin | -5,301.42% |
| EBIT Margin | -5,784.73% |
| FCF Margin | -4,411.93% |
Dividends & Yields
TLIS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.51% |
| Shareholder Yield | -0.51% |
| Earnings Yield | -369.38% |
| FCF Yield | -281.72% |
Analyst Forecast
The average price target for TLIS is $5.00, which is -41.18% lower than the current price. The consensus rating is "Strong Sell".
| Price Target | $5.00 |
| Price Target Difference | -41.18% |
| Analyst Consensus | Strong Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 6, 2023. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jul 6, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
TLIS has an Altman Z-Score of -10.4 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.4 |
| Piotroski F-Score | 2 |